NYSE:BSX Boston Scientific (BSX) Stock Price, News & Analysis $42.82 -1.82 (-4.09%) Closing price 11/6/2026 03:59 PM EasternExtended Trading$42.82 0.00 (0.00%) As of 11/6/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Boston Scientific Stock (NYSE:BSX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Boston Scientific alerts:Sign Up Key Stats Today's Range$42.69▼$43.6350-Day Range$41.55▼$48.4052-Week Range$39.57▼$105.65Volume14.71 million shsAverage Volume20.22 million shsMarket Capitalization$62.06 billionP/E Ratio18.14Dividend YieldN/APrice Target$61.43Consensus RatingModerate Buy Company Overview Boston Scientific is a medical technology company that develops, manufactures and markets devices used in minimally invasive procedures across a range of medical specialties. Founded in 1979, the company is headquartered in Marlborough, Massachusetts. Its products support areas including cardiovascular care, endoscopy, urology and neuromodulation. They include catheter-based devices and therapies for conditions affecting the heart and blood vessels, as well as devices used in diagnostic and therapeutic procedures involving the digestive and urinary systems. Boston Scientific serves healthcare providers and patients around the world. Its portfolio is organized around cardiovascular and MedSurg businesses, reflecting the range of specialties and procedures its products support.AI Generated. May Contain Errors. Read More Boston Scientific Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks83rd Percentile Overall ScoreBSX MarketRank™: 4.149544155665 of 5 starsBoston Scientific scored higher than 83% of companies evaluated by MarketBeat, and ranked 98th out of 886 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingBoston Scientific has received a consensus rating of Moderate Buy. The company's average rating score is 2.65, and is based on 1 strong buy rating, 20 buy ratings, 8 hold ratings, and 2 sell ratings.Upside PotentialBoston Scientific has a consensus price target of $61.43, representing about 43.5% upside from its current price of $42.82.Amount of Analyst CoverageBoston Scientific has been the subject of 20 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Boston Scientific's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth-2.52% Earnings GrowthEarnings for Boston Scientific are expected to decrease by -2.52% in the coming year, from $3.17 to $3.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Boston Scientific is 18.14, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.42.Price to Earnings Ratio vs. SectorThe P/E ratio of Boston Scientific is 18.14, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.49.Price to Earnings Growth RatioBoston Scientific has a PEG Ratio of 1.27. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBoston Scientific has a P/B Ratio of 2.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.82% of the float of Boston Scientific has been sold short.Short Interest Ratio / Days to CoverBoston Scientific has a short interest ratio ("days to cover") of 2.59, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Boston Scientific has recently decreased by 1.70%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBoston Scientific does not currently pay a dividend.Dividend GrowthBoston Scientific does not have a long track record of dividend growth. News and Social Media3.5 / 5News Sentiment0.60 News SentimentBoston Scientific has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 22 news articles for Boston Scientific this week, compared to 8 articles on an average week.Search InterestOnly 65 people have searched for BSX on MarketBeat in the last 30 days. This is a decrease of -22% compared to the previous 30 days.MarketBeat Follows15 people have added Boston Scientific to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Boston Scientific insiders have not sold or bought any company stock.Percentage Held by Insiders0.34% of the stock of Boston Scientific is held by insiders.Percentage Held by Institutions89.07% of the stock of Boston Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Boston Scientific's insider trading history. Receive BSX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BSX Stock News HeadlinesAnalyzing Boston Scientific (NYSE:BSX) & Venus Concept (NASDAQ:VERO)November 7 at 5:53 AM | americanbankingnews.comMedical devices & supplies - diversified stocks Q3 teardown: Boston Scientific (NYSE:BSX) vs the restNovember 4, 2026 | msn.comThe warning signs most investors see too lateDr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. Now, after 55 years of market analysis, he says conditions are forming for a financial crisis that could rival or exceed 2008.November 8 at 1:00 AM | Weiss Ratings (Ad)Boston Scientific (BSX) Secures $455 Million For A Next Generation Heart PumpNovember 4, 2026 | finance.yahoo.comBoston Scientific Held as VITALYST Deal Eases Near-Term Costs but Delays Growth and Adds Long-Term UncertaintyNovember 3, 2026 | tipranks.comBlackstone Life Sciences announces $455M collaboration with Boston ScientificNovember 2, 2026 | tipranks.comBoston Scientific Surges 4.6% After Hours, Adding ~$3B in Market ValueNovember 2, 2026 | 247wallst.comSIMPLAAFY study of the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device meets primary endpointsNovember 2, 2026 | prnewswire.comSee More Headlines BSX Stock Analysis - Frequently Asked Questions How have BSX shares performed this year? Boston Scientific's stock was trading at $95.29 at the beginning of the year. Since then, BSX stock has decreased by 55.1% and is now trading at $42.8160. How were Boston Scientific's earnings last quarter? Boston Scientific Corporation (NYSE:BSX) announced its quarterly earnings results on Wednesday, October, 28th. The medical equipment provider reported $0.73 EPS for the quarter, topping analysts' consensus estimates of $0.73 by $0.00. Boston Scientific's revenue was up 1.4% compared to the same quarter last year. Read the conference call transcript. Is Boston Scientific buying back stock? Boston Scientific's board initiated a share buyback program on Monday, May 18th 2026, which permits the company to buy back $5 billion in outstanding shares, according to EventVestor. This means that the company could repurchase up to 6.4% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's management believes its shares are undervalued. Does Boston Scientific have any subsidiaries? The following companies are subsidiaries of Boston Scientific: VertiFlex, BTG, Augmenix, Veniti, Claret Medical, Cryterion Medical, nVision Medical, and more. Who are Boston Scientific's major shareholders? Top institutional shareholders of Boston Scientific include Assenagon Asset Management S.A. (0.47%), Sumitomo Mitsui Trust Group Inc. (0.23%), Russell Investments Group Ltd. (0.22%) and Aberdeen Group plc (0.22%). Insiders that own company stock include Michael F Mahoney, Daniel J Brennan, Joseph Michael Fitzgerald, Vance R Brown, Eric Francis Yves Thepaut, Edward J Ludwig, Edward J Ludwig, Wendy Carruthers, Jeffrey B Mirviss, Ellen M Zane, Arthur C Butcher, John Bradley Sorenson, David C Habiger, Yoshiaki Fujimori, Cheryl Pegus and Charles J Dockendorff. View institutional ownership trends. How do I buy shares of Boston Scientific? Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Boston Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Boston Scientific investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Intel (INTC), Micron Technology (MU), Tesla (TSLA), Salesforce (CRM) and Visa (V). Company Calendar Last Earnings10/28/2026Today11/08/2026Stifel 2026 Healthcare Conference 202611/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 BSX's financial health is in the Red zone, according to TradeSmith. BSX has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:BSX CIK885725 Webwww.bostonscientific.com Phone(508) 683-4000Fax508-683-5675Employees59,000Year Founded1979Price Target and Rating Average Price Target for Boston Scientific$61.43 High Price Target$118.00 Low Price Target$44.00 Potential Upside/Downside+43.5%Consensus RatingModerate Buy Rating Score (0-4)2.65 Research Coverage31 Analysts Profitability EPS (Trailing Twelve Months)$2.36 Trailing P/E Ratio18.14 Forward P/E Ratio13.86 P/E Growth1.27Net Income$2.90 billion Net Margins16.62% Pretax Margin17.35% Return on Equity18.61% Return on Assets10.58% Debt Debt-to-Equity Ratio0.42 Current Ratio1.36 Quick Ratio0.74 Sales & Book Value Annual Sales$21.07 billion Price / Sales2.95 Cash Flow$4.04 per share Price / Cash Flow10.59 Book Value$17.85 per share Price / Book2.40Miscellaneous Outstanding Shares1,449,473,000Free Float1,444,545,000Market Cap$62.06 billion OptionableOptionable Beta0.60 Social Links 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (NYSE:BSX) was last updated on 11/6/2026 by MarketBeat.com Staff. From Our PartnersEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredThe IRS loophole Trump fought to preserve for retirees401(k) balances have reached record highs on a rising stock market and strong job growth. But traditional acco...American Hartford Gold | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredYour first step can stay on paperIncome Blueprint, created by Matt, helps traders find and evaluate options opportunities. In his walkthrough, ...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boston Scientific Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Boston Scientific With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
